SIRT1 and breast cancer: Importantly, inhibition of SIRT1 by sirtinol, a classic inhibitor of sirtuins, resulted in the activation of p53 and consequently increased p21 protein levels in SK-BR-3 breast cancer cells, thus suggesting a tumor-promoting role of SIRT1 in breast cancer [53].